[go: up one dir, main page]

DK3102949T3 - Diagnose af en neurologisk sygdom - Google Patents

Diagnose af en neurologisk sygdom Download PDF

Info

Publication number
DK3102949T3
DK3102949T3 DK15702809.3T DK15702809T DK3102949T3 DK 3102949 T3 DK3102949 T3 DK 3102949T3 DK 15702809 T DK15702809 T DK 15702809T DK 3102949 T3 DK3102949 T3 DK 3102949T3
Authority
DK
Denmark
Prior art keywords
diagnosis
neurological disease
neurological
disease
Prior art date
Application number
DK15702809.3T
Other languages
English (en)
Inventor
Josep Dalmau
Francesc Graus
Original Assignee
Inst Dinvestigaciones Biomediques August Pi I Sunyer
Inst Catalana Recerca Estudis Avancats
Univ Barcelona
Hospital Clinic Barcelona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Dinvestigaciones Biomediques August Pi I Sunyer, Inst Catalana Recerca Estudis Avancats, Univ Barcelona, Hospital Clinic Barcelona filed Critical Inst Dinvestigaciones Biomediques August Pi I Sunyer
Application granted granted Critical
Publication of DK3102949T3 publication Critical patent/DK3102949T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2864Sleep disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
DK15702809.3T 2014-02-07 2015-02-06 Diagnose af en neurologisk sygdom DK3102949T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14154384.3A EP2905622A1 (en) 2014-02-07 2014-02-07 Diagnosis of a neurological disease
PCT/EP2015/052529 WO2015118115A1 (en) 2014-02-07 2015-02-06 Diagnosis of a neurological disease

Publications (1)

Publication Number Publication Date
DK3102949T3 true DK3102949T3 (da) 2020-11-30

Family

ID=50068912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15702809.3T DK3102949T3 (da) 2014-02-07 2015-02-06 Diagnose af en neurologisk sygdom

Country Status (8)

Country Link
US (2) US20160349275A1 (da)
EP (2) EP2905622A1 (da)
CN (1) CN105934673B (da)
DK (1) DK3102949T3 (da)
ES (1) ES2845935T3 (da)
PL (1) PL3102949T3 (da)
SI (1) SI3102949T1 (da)
WO (1) WO2015118115A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2905622A1 (en) 2014-02-07 2015-08-12 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnosis of a neurological disease
CN109142740A (zh) 2017-06-16 2019-01-04 欧蒙医学诊断技术有限公司 神经自身免疫疾病的诊断
DE102018009721A1 (de) 2017-12-29 2019-07-04 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur Diagnose einer Bornavirus-Infektion
EP3629021A1 (en) 2018-09-26 2020-04-01 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
CN114514240B (zh) * 2019-08-12 2024-11-19 麦考瑞大学 用于治疗的组合物和方法
US11644463B2 (en) 2019-08-30 2023-05-09 Euroimmun Medizinische Labordiagnostika Ag Detection of an autoantibody
US11835519B2 (en) 2019-12-17 2023-12-05 Euroimmun Medizinische Labordiagnostika Ag Autoantibodies to Septin-7 and diagnosis of neurological disease
DE202020000743U1 (de) 2020-02-24 2020-03-17 Euroimmun Medizinische Labordiagnostika Ag Träger und Kit zur Diagnose einer neurologischen Autoimmunkrankheit
EP3872492A1 (en) 2020-02-28 2021-09-01 Seramun Diagnostica GmbH Identifying borna disease virus (bodv) infection through detection of antibodies against the bodv glycoprotein
DE202022104518U1 (de) 2021-08-10 2023-06-20 Fundació Clínic Per A La Recerca Biomèdica (Fcrb) Autoantikörper und Mittel zum Nachweis eines Autoantikörpers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE33717T1 (de) 1983-02-25 1988-05-15 Winfried Dr Med Stoecker Verfahren und vorrichtungen fuer untersuchungen an unbeweglich gemachtem biologischem material.
EP0689455A4 (en) * 1993-03-11 1997-07-23 Univ Southern California THERAPEUTIC STRATEGIES FOR THE TREATMENT OF IMMUNO-INFECTIOUS GROUP VIRAL INFECTIONS
KR0182853B1 (ko) * 1995-08-07 1999-05-15 김신규 자가면역 질환의 진단 방법
US20060003323A1 (en) * 2000-03-01 2006-01-05 John Alsobrook Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002072794A2 (en) * 2001-03-12 2002-09-19 Incyte Genomics, Inc. Immunoglobulin superfamily proteins
WO2002074906A2 (en) * 2001-03-16 2002-09-26 Eli Lilly And Company Lp mammalian proteins; related reagents
WO2008061013A2 (en) 2006-11-10 2008-05-22 Amgen Inc. Antibody-based diagnostics and therapeutics
EA201391521A1 (ru) * 2011-04-13 2014-03-31 Ревалезио Корпорейшн Композиции и способы для ингибирования и/или модулирования эффекторных t-клеток, участвующих в воспалительном нейродегенеративном заболевании
DE202011106093U1 (de) 2011-09-24 2011-10-19 Euroimmun Medizinische Labordiagnostika Ag Kalibrationsstreifen für einen Immunoblot
EP2905622A1 (en) 2014-02-07 2015-08-12 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnosis of a neurological disease

Also Published As

Publication number Publication date
CN105934673A (zh) 2016-09-07
EP3102949A1 (en) 2016-12-14
EP2905622A1 (en) 2015-08-12
PL3102949T3 (pl) 2021-05-17
WO2015118115A1 (en) 2015-08-13
EP3102949B1 (en) 2020-10-28
CN105934673B (zh) 2020-11-27
SI3102949T1 (sl) 2021-02-26
US20160349275A1 (en) 2016-12-01
US10962554B2 (en) 2021-03-30
ES2845935T3 (es) 2021-07-28
US20180335439A1 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
DK3226763T3 (da) Billeddannelse af en krop
IL258418B (en) Representative diagnostics
DK3102949T3 (da) Diagnose af en neurologisk sygdom
DK3117030T3 (da) Diagnosticering af sepsis
PL3998070T3 (pl) Mir-124 jako biomarker do leczenia chorób zapalnych
EP3129952C0 (en) Tethered endoscope
EP3240438C0 (en) Hydrophobic filter
CL2014001946S1 (es) Foco delantero de un automovil
DK3024501T3 (da) Billeddannelse af neurologisk sygdom
DK3105320T3 (da) Syntetisk nethinde
EP3690063C0 (en) DIAGNOSIS OF LUNG CANCER
EP3289106A4 (en) DIAGNOSTIC PROCEDURE
DK3166473T3 (da) Oftalmoskoper
DK3190964T3 (da) Spirometer
EP3632505C0 (en) NON-INVASIVE NEUROMODULATION
HUE046721T2 (hu) Diagnosztikai módszer
MA47259A (fr) Diagnostic
DK3237019T3 (da) Formulering af hypericin til fotodynamisk diagnose
DK2997384T3 (da) Fremgangsmåde til diagnose af niemann-pick sygdom
EP3552576A4 (en) Filter
IL251879A0 (en) A method for diagnosing Niemann-Pick disease using a biomarker
LT3298042T (lt) B-ląstelių naikinimas kaip diagnostinis žymuo
EP3602132A4 (en) "REFLUX DISEASE DIAGNOSIS"
EP3400999A4 (en) FILTER
CO6990723A2 (es) Métodos de diagnóstico